Teva Pharmaceuticals
TEVA
TEVA
445 hedge funds and large institutions have $6.16B invested in Teva Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 132 increasing their positions, 143 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
445
Holders Change
+12
Holders Change %
+2.77%
% of All Funds
6.52%
Holding in Top 10
20
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+5.26%
% of All Funds
0.29%
New
67
Increased
132
Reduced
143
Closed
47
Calls
$165M
Puts
$174M
Net Calls
-$8.93M
Net Calls Change
-$112M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$172M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$121M |
| 3 |
Millennium Management
New York
|
$157M |
| 4 |
GAM
Goldentree Asset Management
New York
|
$40.5M |
| 5 |
MRCP
Maple Rock Capital Partners
Toronto,
Ontario, Canada
|
$27.1M |
